Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carotid ultrasound-guided cardiovascular prevention strategy in inflammatory rheumatic diseases
2025-521086-28-00Phase 4Authorised
- Sponsor
- IDIVAL
- Start
- Mar 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rosuvastatin, ezetimibe, bempedoic acid, atorvastatin and amlodipine in cardiac morbidity (2 arms), sponsored by IDIVAL. Planned start Mar 2026; status: authorised.
02
Drugs
rosuvastatinezetimibebempedoic acidatorvastatinamlodipine
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2025-521086-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521086-28-00.